Enhertu significantly delayed breast cancer progression in trial, AstraZeneca says
AstraZeneca PLC said Monday that its Enhertu drug significantly delayed metastatic breast cancer progression in…
Read MoreAstraZeneca PLC said Monday that its Enhertu drug significantly delayed metastatic breast cancer progression in…
Read MoreAs a clinical psychologist at the Imperial College London, Rosalind Watts witnessed hundreds of patients…
Read MoreThe daily average of new U.S. cases may have started to decline based on official…
Read MoreThe daily average of new U.S. cases may have started to decline based on official…
Read MoreWant a more economically equal society? Start with your inner circle — or your child’s.…
Read MoreModerna MRNA, +3.81% and Pfizer PFE, -0.41% have not yet started clinical trials for the…
Read MoreStephanie Walker, a Black retired nurse who was diagnosed with metastatic breast cancer in 2015,…
Read More